PDF herunterladen
Am J Perinatol 2024; 41(S 01): e2613-e2621
DOI: 10.1055/s-0043-1772747
Original Article

Respiratory Severity Score during the First 3 Hours of Life as a Predictor for Failure of Noninvasive Respiratory Support and Need for Late Rescue Surfactant Administration

Henry A. Zapata 
1   Division of Neonatology, Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin
,
Heather L. Becker
2   Department of Respiratory Therapy, UnityPoint-Meriter, Madison, Wisconsin
,
Michael R. Lasarev 
3   Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin
,
Prem Fort
4   Division of Neonatology, Department of Pediatrics, Johns Hopkins All Children's Hospital, St. Peterburg, Florida
,
Scott O. Guthrie 
5   Division of Neonatology, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee
,
Dinushan C. Kaluarachchi 
1   Division of Neonatology, Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin
› Institutsangaben Funding None.
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective Preterm infants often develop failure of noninvasive respiratory support. These infants miss the advantages of early rescue surfactant therapy. In this study, we evaluate the utility of respiratory severity score (RSS) during the first 3 hours of life (HOL) as a predictor for failure of noninvasive respiratory support.

Study Design We conducted a post hoc analysis of infants between 23 and 40 weeks' gestational age who received usual care in the AERO-02 clinical trial. Univariate and multivariable logistic regression analysis were used to assess whether the RSS summary measures were associated with the odds of surfactant administration.

Results Study involved 146 infants. Sixty-four infants (45%) received surfactant within the first 72 hours. Administration of surfactant was associated with the mean RSS (p < 0.01) and the linear trend (p < 0.01).

Conclusion We demonstrated that RSS during the first 3 HOL can predict failure of noninvasive respiratory support and need for late rescue surfactant administration. Optimal RSS cutoffs for early rescue surfactant therapy need to be determined in large cohort studies.

Key Points

  • Early recognition of infants at risk of failure of noninvasive ventilation is important to prevent complications.

  • It is desirable to identify patients who would benefit from early rescue surfactant treatment.

  • RSS in first 3 hours can be used as a predictor of failure of noninvasive respiratory support.

Keywords

respiratory distress syndrome - surfactant - early rescue surfactant - CPAP failure - respiratory severity score

Supplementary Material



Publikationsverlauf

Eingereicht: 23. Januar 2023

Angenommen: 18. Juli 2023

Artikel online veröffentlicht:
24. August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Warren JB, Anderson JM. Core concepts: respiratory distress syndrome. Neoreviews 2009; 10: 351-361
    CrossrefPubMedGoogle Scholar
  • 2 Committee on Fetus and Newborn. American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics 2014; 133 (01) 171-174
    CrossrefPubMedGoogle Scholar
  • 3 Sweet DG, Carnielli V, Greisen G. et al. European consensus guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology 2019; 115 (04) 432-450
    CrossrefPubMedGoogle Scholar
  • 4 Glaser K, Bamat NA, Wright CJ. Can we balance early exogenous surfactant therapy and non-invasive respiratory support to optimise outcomes in extremely preterm infants? A nuanced review of the current literature. Arch Dis Child Fetal Neonatal Ed 2022:fetalneonatal-2022-324530
    PubMedGoogle Scholar
  • 5 Sood BG, Thomas R, Delaney-Black V, Xin Y, Sharma A, Chen X. Aerosolized Beractant in neonatal respiratory distress syndrome: a randomized fixed-dose parallel-arm phase II trial. Pulm Pharmacol Ther 2021; 66: 101986
    CrossrefPubMedGoogle Scholar
  • 6 Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr Res 2017; 81 (1-2): 240-248
    CrossrefPubMedGoogle Scholar
  • 7 Challis P, Nydert P, Håkansson S, Norman M. Association of adherence to surfactant best practice uses with clinical outcomes among neonates in Sweden. JAMA Netw Open 2021; 4 (05) e217269
    CrossrefPubMedGoogle Scholar
  • 8 Patel P, Houck A, Fuentes D. Examining variations in surfactant administration (ENVISION): a neonatology insights pilot project. Children (Basel) 2021; 8 (04) 261
    PubMedGoogle Scholar
  • 9 Aly H, Mohamed MA. An experience with a bubble CPAP bundle: is chronic lung disease preventable?. Pediatr Res 2020; 88 (03) 444-450
    CrossrefPubMedGoogle Scholar
  • 10 Merrill JD, Ballard RA, Cnaan A. et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004; 56 (06) 918-926
    CrossrefPubMedGoogle Scholar
  • 11 Jung YH, Jang J, Kim HS. et al. Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants. BMC Pediatr 2019; 19 (01) 121
    CrossrefPubMedGoogle Scholar
  • 12 Malkar MB, Gardner WP, Mandy GT. et al. Respiratory severity score on day of life 30 is predictive of mortality and the length of mechanical ventilation in premature infants with protracted ventilation. Pediatr Pulmonol 2015; 50 (04) 363-369
    CrossrefPubMedGoogle Scholar
  • 13 Mhanna MJ, Iyer NP, Piraino S, Jain M. Respiratory severity score and extubation readiness in very low birth weight infants. Pediatr Neonatol 2017; 58 (06) 523-528
    CrossrefPubMedGoogle Scholar
  • 14 Katz LA, Klein JM. Repeat surfactant therapy for postsurfactant slump. J Perinatol 2006; 26 (07) 414-422
    CrossrefPubMedGoogle Scholar
  • 15 Cummings JJ, Gerday E, Minton S. et al; AERO-02 STUDY INVESTIGATORS. Aerosolized calfactant for newborns with respiratory distress: a randomized trial. Pediatrics 2020; 146 (05) e20193967
    CrossrefPubMedGoogle Scholar
  • 16 Dargaville PA, Gerber A, Johansson S. et al; Australian and New Zealand Neonatal Network. Australian, New Zealand Neonatal Network: incidence and outcome of CPAP failure in preterm infants. Pediatrics 2016; 138 (01) e20153985
    CrossrefPubMedGoogle Scholar
  • 17 Dargaville PA, Aiyappan A, De Paoli AG. et al. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology 2013; 104 (01) 8-14
    CrossrefPubMedGoogle Scholar
  • 18 Ammari A, Suri M, Milisavljevic V. et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005; 147 (03) 341-347
    CrossrefPubMedGoogle Scholar
  • 19 De Jaegere AP, van der Lee JH, Canté C, van Kaam AH. Early prediction of nasal continuous positive airway pressure failure in preterm infants less than 30 weeks gestation. Acta Paediatr 2012; 101 (04) 374-379
    CrossrefPubMedGoogle Scholar
  • 20 Fuchs H, Lindner W, Leiprecht A, Mendler MR, Hummler HD. Predictors of early nasal CPAP failure and effects of various intubation criteria on the rate of mechanical ventilation in preterm infants of <29 weeks gestational age. Arch Dis Child Fetal Neonatal Ed 2011; 96 (05) F343-F347
    CrossrefPubMedGoogle Scholar
  • 21 Tagliaferro T, Bateman D, Ruzal-Shapiro C, Polin RA. Early radiologic evidence of severe respiratory distress syndrome as a predictor of nasal continuous positive airway pressure failure in extremely low birth weight newborns. J Perinatol 2015; 35 (02) 99-103
    CrossrefPubMedGoogle Scholar
  • 22 Kakkilaya V, Wagner S, Mangona KLM. et al. Early predictors of continuous positive airway pressure failure in preterm neonates. J Perinatol 2019; 39 (08) 1081-1088
    CrossrefPubMedGoogle Scholar
  • 23 Iyer NP, Mhanna MJ. Non-invasively derived respiratory severity score and oxygenation index in ventilated newborn infants. Pediatr Pulmonol 2013; 48 (04) 364-369
    CrossrefPubMedGoogle Scholar
  • 24 Hatch LD, Grubb PH, Lea AS. et al. Endotracheal intubation in neonates: a prospective study of adverse safety events in 162 infants. J Pediatr 2016; 168: 62-66.e6
    CrossrefPubMedGoogle Scholar
  • 25 Herting E, Härtel C, Göpel W. Less invasive surfactant administration: best practices and unanswered questions. Curr Opin Pediatr 2020; 32 (02) 228-234
    CrossrefPubMedGoogle Scholar
  • 26 Dargaville PA, Kamlin COF, Orsini F. et al; OPTIMIST-A Trial Investigators. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST-a randomized clinical trial. JAMA 2021; 326 (24) 2478-2487
    CrossrefPubMedGoogle Scholar
  • 27 Zapata HA, Fort P, Roberts KD, Kaluarachchi DC, Guthrie SO. Surfactant administration through laryngeal or supraglottic airways (SALSA): a viable method for low-income and middle-income countries. Front Pediatr 2022; 10: 853831
    CrossrefPubMedGoogle Scholar
  • 28 Roberts KD, Brown R, Lampland AL. et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial. J Pediatr 2018; 193: 40-46.e1
    CrossrefPubMedGoogle Scholar
  • 29 Gaertner VD, Thomann J, Bassler D, Rüegger CM. Surfactant nebulization to prevent intubation in preterm infants: a systematic review and meta-analysis. Pediatrics 2021; 148 (05) e2021052504
    CrossrefPubMedGoogle Scholar
  • 30 Kakkilaya V, Gautham KS. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?. Pediatr Res 2023; 93 (05) 1188-1198
    CrossrefPubMedGoogle Scholar
  • 31 Isayama T, Iwami H, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis. JAMA 2016; 316 (06) 611-624
    CrossrefPubMedGoogle Scholar
  • 32 Trembath A, Hornik CP, Clark R, Smith PB, Daniels J, Laughon M. Best Pharmaceuticals for Children Act—Pediatric Trials Network. Comparative effectiveness of surfactant preparations in premature infants. J Pediatr 2013; 163 (04) 955-60.e1
    CrossrefPubMedGoogle Scholar